Serina Therapeutics (SER) Gross Margin (2018 - 2023)
Serina Therapeutics (SER) recorded Gross Margin of 1.78% in Q4 2023, down 85.72 percentage points from 87.50% a year earlier and down 115.46 percentage points from the prior quarter.
Powered by 
Analysis
Serina Therapeutics (SER) Gross Margin (2018 - 2023) Analysis & Trends
For FY2023, Serina Therapeutics reported Gross Margin of 3.24%, down 58.53 percentage points from FY2022.
- Annual Gross Margin has declined for three straight years, with a five-year change of -70.69 percentage points (FY2018 to FY2023).
- Across earlier years, Gross Margin came in at 61.76% in FY2022 (-25.04 pp), 86.81% in FY2021 (-5.99 pp), 92.80% in FY2020 (+6.92 pp) and 85.88% in FY2019 (+11.95 pp).
- The Q4 2023 figure is the lowest quarterly Gross Margin in data going back to Q2 2018.
- On a year-over-year basis, Gross Margin rose in two of the last eight quarters, with an average year-over-year change of -17.66 percentage points.
- Peak year-over-year performance for Gross Margin in the last five years was a gain of 72.80 percentage points in Q3 2023, against a drop of 85.72 percentage points in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 117.24% (Q3 2023), 57.14% (Q2 2023) and 30.00% (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 85.78% |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 74.74% |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 73.54% |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 72.04% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 79.76% |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 72.78% |
| 10 | Serina Therapeutics | 29.17 Mn | -11.58 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 1.78% |
| Sep 30, 2023 | 117.24% |
| Jun 30, 2023 | 57.14% |
| Mar 31, 2023 | 30.00% |
| Dec 31, 2022 | 87.50% |
| Sep 30, 2022 | 44.44% |
| Jun 30, 2022 | 50.00% |
| Mar 31, 2022 | 80.00% |
| Dec 31, 2021 | 96.30% |
| Sep 30, 2021 | 91.67% |
| Jun 30, 2021 | 64.86% |
| Mar 31, 2021 | 94.64% |
| Dec 31, 2020 | 96.84% |
| Sep 30, 2020 | 75.36% |
| Jun 30, 2020 | 93.33% |
| Mar 31, 2020 | 98.88% |
| Dec 31, 2019 | 85.61% |
| Sep 30, 2019 | 88.08% |
| Jun 30, 2019 | 86.05% |
| Mar 31, 2019 | 83.76% |
API Access
Serina Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=SER&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "SER", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=SER&period=max&api_key=YOUR_API_KEY");
const data = await res.json();